Mandart E, Parker R
Department of Molecular and Cellular Biology, University of Arizona, Tucson 85721, USA.
Mol Cell Biol. 1995 Dec;15(12):6979-86. doi: 10.1128/MCB.15.12.6979.
The RNA14 and RNA15 gene products have been implicated in a variety of cellular processes. Mutations in these genes lead to faster decay of some mRNAs and yield extracts that are deficient in cleavage and polyadenylation in vitro. These results suggest that the RNA14 and RNA15 gene products may be involved in both adenylation and deadenylation in vivo. To explore the roles of these gene products in vivo, we examined the site of adenylation and the rate of deadenylation for individual mRNAs in rna14 and rna15 mutant strains. We observed that the rates of deadenylation are not affected by lesions in either the RNA14 or the RNA15 gene. This result suggests that the proteins encoded by these genes are not involved in regulation of the deadenylation rate. In contrast, we observed that the site of adenylation for the ACT1 transcript can be altered in these mutants. Interestingly, we also observed that mutation of the poly(A) polymerase gene altered the site of ACT1 polyadenylation. These observations suggest that the RNA14, RNA15, and PAP1 proteins are involved in poly(A) site choice. This alteration in poly(A) site choice in the rna14 mutant can be corrected by the ssm4 suppressor, indicating that this suppression acts at the level of polyadenylation and not by slowing mRNA degradation.
RNA14和RNA15基因产物参与了多种细胞过程。这些基因的突变导致一些mRNA更快地降解,并产生在体外切割和聚腺苷酸化方面存在缺陷的提取物。这些结果表明,RNA14和RNA15基因产物可能在体内参与腺苷酸化和去腺苷酸化过程。为了探究这些基因产物在体内的作用,我们检测了rna14和rna15突变菌株中单个mRNA的腺苷酸化位点和去腺苷酸化速率。我们观察到,RNA14或RNA15基因的损伤均不影响去腺苷酸化速率。这一结果表明,这些基因编码的蛋白质不参与去腺苷酸化速率的调控。相反,我们观察到在这些突变体中,ACT1转录本的腺苷酸化位点会发生改变。有趣的是,我们还观察到聚腺苷酸聚合酶基因突变会改变ACT1的聚腺苷酸化位点。这些观察结果表明,RNA14、RNA15和PAP1蛋白参与了聚腺苷酸位点的选择。rna14突变体中聚腺苷酸位点选择的这种改变可以被ssm4抑制子纠正,这表明这种抑制作用发生在聚腺苷酸化水平,而不是通过减缓mRNA降解来实现的。